CNS Pharmaceuticals, Inc. SEC filings CNSP

CNS Pharmaceuticals, Inc. has 390 filings in SEC EDGAR's recent list, going back to Mar 13, 2018. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 2, 2026 (officer or director change, shareholder vote results). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K/A Amended annual report Apr 30, 2026 Dec 31, 2025
10-K Annual report Mar 31, 2026 Dec 31, 2025
ARS Annual report to shareholders Oct 28, 2025 Dec 31, 2024
10-K/A Amended annual report Apr 30, 2025 Dec 31, 2024
10-K Annual report Mar 31, 2025 Dec 31, 2024
10-K Annual report Apr 1, 2024 Dec 31, 2023
10-K/A Amended annual report May 1, 2023 Dec 31, 2022
10-K Annual report Mar 31, 2023 Dec 31, 2022
10-K/A Amended annual report Apr 29, 2022 Dec 31, 2021
10-K Annual report Mar 3, 2022 Dec 31, 2021
10-K/A Amended annual report Apr 30, 2021 Dec 31, 2020
10-K/A Amended annual report Feb 16, 2021 Dec 31, 2020
10-K Annual report Feb 12, 2021 Dec 31, 2020
10-K Annual report Mar 12, 2020 Dec 31, 2019

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CNSP (Nasdaq)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Houston, TX
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1729427

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.